Related Experiment Video
Updated: May 10, 2025
08:17
A Proximal Culture Method to Study Paracrine Signaling Between Cells
Published on: August 28, 2018
9.4K
RON Receptor Signaling and the Tumor Microenvironment
Emily Wachter1, Levi H Fox1, Zhixin Lu1
1Department of Cancer Biology, University of Cincinnati College of Medicine, Cincinnati, OH 45267-0521, USA.
Genes
|April 26, 2025
Summary
The RON receptor tyrosine kinase influences cancer growth by affecting the tumor microenvironment. Understanding its signaling in cancer cells and immune cells is key for future therapies.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- The tumor microenvironment is crucial for cancer progression and is modulated by immune cell signaling.
- The RON receptor tyrosine kinase (RTK) is implicated in growth and wound healing and is overexpressed in many cancers.
- RON is expressed by various cells, including epithelial cells and immune cells like macrophages and dendritic cells.
Purpose of the Study:
- To review the literature on the roles of tumor cell-intrinsic and -extrinsic RON signaling in cancer.
- To highlight the influence of RON-expressing tumors on the tumor immune microenvironment.
- To identify knowledge gaps and future research directions for targeting RON signaling in cancer.
Main Methods:
- Literature review and synthesis of existing research on RON receptor tyrosine kinase.
- Analysis of studies investigating RON expression and function in various cancer types.
- Examination of the impact of RON signaling on immune cells within the tumor microenvironment.
Main Results:
- RON receptor tyrosine kinase signaling is a significant factor in tumor growth and development.
- Tumor cell-intrinsic and -extrinsic RON signaling pathways modulate the immune microenvironment.
- Overexpression of RON in cancer cells impacts interactions with immune cells like macrophages and dendritic cells.
Conclusions:
- RON receptor tyrosine kinase plays a multifaceted role in cancer, influencing both tumor cells and the immune microenvironment.
- Further research into RON signaling is warranted to explore its therapeutic potential in oncology.
- Targeting RON signaling may offer novel strategies for cancer treatment by modulating the tumor immune microenvironment.
Related Concept Videos
02:17The Tumor Microenvironment
6.4K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.4K
01:15Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
03:03mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
02:38Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
01:31Internal Receptors
68.4K
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
68.4K
01:26Receptor Tyrosine Kinases
11.7K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
11.7K